Literature DB >> 16555048

[Bone marrow edema in the knee. Differential diagnosis and therapeutic possibilities].

S Hofmann1, J Kramer, M Breitenseher, M Pietsch, N Aigner.   

Abstract

The Bone marrow edema (BME) is a common finding when evaluating patients with knee pain by magnetic resonance imaging (MRI). The typical signal patterns of BME are unspecific and can be found with different diseases of the knee. Since different therapeutic approaches are mandatory, differential diagnosis of the several forms of BME is important. In this review, painful BME will be separated into three different etiological groups. Group 1 ischemic BME: osteonecrosis, osteochondritis dissecans, bone marrow edema syndrome and complex regional pain syndrome. Group 2 mechanical BME: bone bruises, microfracture, stress-BME und stress fracture. Group 3 reactive BME: inflammatory gonarthritis, degenerative gonarthrosis, postoperative and tumours. The typical MRI morphologies and differential diagnosis of these BME manifestations will be described. The different therapeutic consequences will also be briefly mentioned.

Entities:  

Mesh:

Year:  2006        PMID: 16555048     DOI: 10.1007/s00132-006-0952-8

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  33 in total

Review 1.  Optimized diagnostic angiography in high-risk patients with severe peripheral vascular disease.

Authors:  J Gates; G G Hartnell
Journal:  Radiographics       Date:  2000 Jan-Feb       Impact factor: 5.333

2.  Bone marrow edema syndrome of the femoral head: treatment with the prostacyclin analogue iloprost vs. core decompression: an MRI-controlled study.

Authors:  Nicolas Aigner; Gert Petje; Wolfgang Schneider; Roland Meizer; Matthias Wlk; Spyridon Kotsaris; Karl Knahr; Franz Landsiedl
Journal:  Wien Klin Wochenschr       Date:  2005-02       Impact factor: 1.704

Review 3.  Stress fractures: current concepts.

Authors:  R H Daffner; H Pavlov
Journal:  AJR Am J Roentgenol       Date:  1992-08       Impact factor: 3.959

Review 4.  [Differential diagnosis of bone marrow edema of the knee joint].

Authors:  M J Breitenseher; J Kramer; M E Mayerhoefer; N Aigner; S Hofmann
Journal:  Radiologe       Date:  2006-01       Impact factor: 0.635

5.  Juxta-articular bone marrow signal changes on magnetic resonance imaging following arthroscopic meniscectomy.

Authors:  Yasukazu Kobayashi; Masashi Kimura; Hiroshi Higuchi; Masanori Terauchi; Kenji Shirakura; Kenji Takagishi
Journal:  Arthroscopy       Date:  2002-03       Impact factor: 4.772

Review 6.  Treatment of complex regional pain syndrome of the lower extremity.

Authors:  Christopher J Hogan; Shepard R Hurwitz
Journal:  J Am Acad Orthop Surg       Date:  2002 Jul-Aug       Impact factor: 3.020

7.  Osteonecrosis of the medial part of the tibial plateau.

Authors:  M L Ecker; P A Lotke
Journal:  J Bone Joint Surg Am       Date:  1995-04       Impact factor: 5.284

8.  Intracortical chondroblastoma mimicking intra-articular osteoid osteoma.

Authors:  Tsuyoshi Ishida; Takahiro Goto; Noriko Motoi; Kiyoshi Mukai
Journal:  Skeletal Radiol       Date:  2002-08-28       Impact factor: 2.199

9.  Osteonecrosis of the knee following arthroscopic meniscectomy in patients over 50-years old.

Authors:  D L Muscolo; M Costa-Paz; A Makino; M A Ayerza
Journal:  Arthroscopy       Date:  1996-06       Impact factor: 4.772

10.  Bone-marrow oedema syndrome and transient osteoporosis of the hip. An MRI-controlled study of treatment by core decompression.

Authors:  S Hofmann; A Engel; A Neuhold; K Leder; J Kramer; H Plenk
Journal:  J Bone Joint Surg Br       Date:  1993-03
View more
  13 in total

1.  [Pathophysiology of traumatic bone marrow edema].

Authors:  V Quack; M Betsch; H Schenker; J Beckmann; B Rath; C Lüring; M Tingart
Journal:  Unfallchirurg       Date:  2015-03       Impact factor: 1.000

2.  Bisphosphonates or prostacyclin in the treatment of bone-marrow oedema syndrome of the knee and foot.

Authors:  Clemens Baier; Jens Schaumburger; Jürgen Götz; Guido Heers; Thorsten Schmidt; Joachim Grifka; Johannes Beckmann
Journal:  Rheumatol Int       Date:  2012-11-10       Impact factor: 2.631

3.  [Surgical treatment of knee joint osteoarthritis in the middle-aged patient].

Authors:  Martin Pietsch; Siegfried Hofmann
Journal:  Wien Med Wochenschr       Date:  2007-01

4.  Acute nontraumatic adult knee pain: the role of MR imaging.

Authors:  A Fotiadou; A Karantanas
Journal:  Radiol Med       Date:  2009-04-14       Impact factor: 3.469

Review 5.  Bone marrow edema syndrome.

Authors:  Anastasios V Korompilias; Apostolos H Karantanas; Marios G Lykissas; Alexandros E Beris
Journal:  Skeletal Radiol       Date:  2008-07-16       Impact factor: 2.199

Review 6.  [Bone marrow edema and atraumatic necrosis of the femoral head : Therapy].

Authors:  J Beckmann; A Roth; C Niethard; F Mauch; R Best; U Maus
Journal:  Orthopade       Date:  2015-09       Impact factor: 1.087

7.  The relationship between bone marrow edema size and knee pain.

Authors:  Koray Unay; Oguz Poyanli; Kaya Akan; Melih Guven; Can Demircay
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-06-26       Impact factor: 4.342

8.  Validation of a Novel Semiautomated Segmentation Method for MRI Detection of Cartilage-Related Bone Marrow Lesions.

Authors:  A J Dijkstra; P Anbeek; K G Auw Yang; K L Vincken; M A Viergever; R M Castelein; D B F Saris
Journal:  Cartilage       Date:  2010-10       Impact factor: 4.634

9.  Extracorporeal Shock Wave Therapy Is Effective in the Treatment of Bone Marrow Edema of the Medial Compartment of the Knee: A Comparative Study.

Authors:  Valerio Sansone; Pietro Romeo; Vito Lavanga
Journal:  Med Princ Pract       Date:  2016-10-25       Impact factor: 1.927

10.  Extracorporeal shock wave therapy in the treatment of primary bone marrow edema syndrome of the knee: a prospective randomised controlled study.

Authors:  Fuqiang Gao; Wei Sun; Zirong Li; Wanshou Guo; Weiguo Wang; Liming Cheng; Debo Yue; Nianfei Zhang; Amanda Savarin
Journal:  BMC Musculoskelet Disord       Date:  2015-12-05       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.